Operator: Good afternoon, and welcome to the Ultragenyx Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
By Denny Jacob Ultragenyx Pharmaceutical shares rose 14% to $38.18 following interim data from ongoing studies. The stock is down 18% on the year so far. The.